Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Second primary non-myeloid malignancies following intensive treatment for adult acute myeloid leukaemia: a Danish population-based cohort study.
Nielsen NN, Jensen JF, Baech J, Trab T, El-Galaly TC, Schöllkopf C, Ørskov AD, Ommen HB, Granfeldt LS, Kristensen DT, Severinsen MT. Nielsen NN, et al. Among authors: orskov ad. Lancet Reg Health Eur. 2024 Dec 30;50:101204. doi: 10.1016/j.lanepe.2024.101204. eCollection 2025 Mar. Lancet Reg Health Eur. 2024. PMID: 39844882 Free PMC article.
Bone marrow microenvironment signatures associate with patient survival after guadecitabine and atezolizumab therapy in HMA-resistant MDS.
Jang HJ, Urrutia G, Orskov AD, Kim HJ, Nelson SA, Nguyen AV, Lee H, Burgos RS, Johnson BK, Wegener M, Becker K, Adams M, Sheridan R, Ramjan ZH, Givan SA, Zebley CC, Youngblood BA, Issa JJ, Topper MJ, Baylin SB, Baer MR, Triche TJ, O'Connell CL, Gronbaek K, Jones PA. Jang HJ, et al. Among authors: orskov ad. bioRxiv [Preprint]. 2024 Nov 11:2024.11.08.622670. doi: 10.1101/2024.11.08.622670. bioRxiv. 2024. PMID: 39605731 Free PMC article. Preprint.
Temporal changes in survival among adult patients with acute lymphoblastic leukaemia diagnosed in the period 1998-2020 - A Danish nationwide population-based cohort study.
Kristensen DT, Jåtun TL, Simonsen MR, Toft N, Dimitrijevic A, Ørskov AD, Roug AS, El-Galaly TC, Severinsen MT. Kristensen DT, et al. Among authors: orskov ad. Eur J Cancer. 2024 Nov;212:114338. doi: 10.1016/j.ejca.2024.114338. Epub 2024 Sep 21. Eur J Cancer. 2024. PMID: 39326288 Free article.
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine.
O'Connell CL, Baer MR, Ørskov AD, Saini SK, Duong VH, Kropf P, Hansen JW, Tsao-Wei D, Jang HS, Emadi A, Holmberg-Thyden S, Cowland J, Brinker BT, Horwood K, Burgos R, Hostetter G, Youngblood BA, Hadrup SR, Issa JP, Jones P, Baylin SB, Siddiqi I, Grønbaek K. O'Connell CL, et al. Among authors: orskov ad. Clin Cancer Res. 2022 Dec 15;28(24):5306-5316. doi: 10.1158/1078-0432.CCR-22-1810. Clin Cancer Res. 2022. PMID: 36222848 Free PMC article. Clinical Trial.
Mutations known from B-cell lymphoid malignancies are not found in CD34+ stem cells from patients with lymphoma.
Husby S, Favero F, Rodriguez-Gonzalez FG, Sutton LA, Haastrup EK, Ørskov AD, Hansen JW, Arboe B, Aslan D, Clasen-Linde E, Rahbek Gjerdrum LM, Gørlev JS, Brown P, Fischer-Nielsen A, Rosenquist R, Weischenfeldt J, Grønbæk K. Husby S, et al. Among authors: orskov ad. Leuk Lymphoma. 2021 Nov;62(11):2808-2811. doi: 10.1080/10428194.2021.1933473. Epub 2021 Jun 21. Leuk Lymphoma. 2021. PMID: 34151700 No abstract available.
20 results